Cannabis Science Presents Photographic Evidence Showing Cannabis Shrinking Cancer Tumors

Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to share new photographs from this cancer patient with severe squamous cell carcinoma. These pictures clearly show that this patient, with previously treatment-resistant tumors, continues to make obvious improvement. The tumors appear to be dying and then healing after treatment with cannabis-based extracts.

Cannabis Science has been working closely with this patient who has multiple squamous cell carcinoma tumors on his head. The latest pictures indicate that this patient is making dramatic improvement using cannabis-extract topical therapy under scientific guidance from Cannabis Science.

Marijuana Is Here To Stay

The only way for our society to realize the full potential of cannabis, including its full medical potential, is to free it from the regulations controlling prescription drugs and the criminal laws controlling psychoactive substances, writes Harvard Medical Professor Dr. Lester Grinspoon.

In 1967, because of my concern about the rapidly growing use of the dangerous drug marijuana, I began my studies of the scientific and medical literature with the goal of providing a reasonably objective summary of the data which underlay its prohibition.
Much to my surprise, I found no credible scientific basis for the justification of the prohibition. The assertion that it is a very toxic drug is based on old and new myths. In fact, one of the many exceptional features of this drug is its remarkably limited toxicity. Compared to aspirin, which people are free to purchase and use without the advice or prescription of a physician, cannabis is much safer: there are well over 1000 deaths annually from aspirin in the United States alone, whereas there has never been a death anywhere from marijuana.

Living Outside The Marijuana Laws: The Duality Of Honesty

Welcome to the duality of honesty. 

Clancy is a master-grower. He lives deep up on one of those canyon drives that seems so off the beaten path that it's hard to believe someone actually lives there.  Barely in his 30s, Clancy's a kid in terms of the hills and cultivation, but unlike many of his youthful contemporaries, he studies the old ways.

There are rumors that today's third generation growers doesn't care squat about growing in the sun. That the kids today will go indoor, outdoor, light deprivation, green house, even in a warehouse: It's said that they grow to follow the money.

S.F. Marijuana Dispensaries Annual Sales Estimate: $41 Million

In an unprecedented analysis of sales tax revenue from the sale of medical marijuana at city dispensaries, the San Francisco controller's office has estimated annual sales of medicinal cannabis at $41 million.

San Francisco's roughly two dozen licensed collectives must pay the city's 8.5 percent sales tax rate, coming from California's 7.25 percent sales tax with a local one percent sales tax going to S.F.'s general fund, and a .25 percent sales tax that goes to other areas like transportation, reports David Downs at the East Bay Express.